Wednesday, February 14, 2018
A competition for radical ideas in the fight against blindness will move to its next phase by challenging participants to build functioning human retina prototypes. The National Eye Institute (NEI) 3-D Retina Organoid Challenge (NEI 3-D ROC 2020) is a $1-million federal prize competition designed to generate lab-grown human retinas from stem cells. Organoids developed for the competition will mimic the structure, organization, and function of the human retina, the light-sensitive tissue in the back of the eye. NEI is part of the National Institutes of Health.
Expedited development of new treatments for the 285 million people worldwide who are visually impaired, including 39 million who are blind, are desperately needed. Efforts to understand and cure vision-depleting retinal diseases such as age-related macular degeneration and diabetic retinopathy are limited by the lack of tissue models. “Mini-retinas” developed under 3-D ROC 2020 would replicate the complexity and functionality of the human retina, and serve as a platform to study underlying causes of retinal diseases, test new drug therapies, and provide a source of cells for transplantation.
3-D ROC 2017, the Ideation phase, awarded $90,000 to Erin Lavik, Sc.D., at the University of Maryland, Baltimore County, for her concept to screen-print retinal neurons in layers to mimic the structure of the human retina.
The implementation challenge, 3-D ROC 2020, calls for the generation of 3-D prototype organoids and demonstration that they function as disease models or drug screening tools. Participants need not have competed in the ideation phase to compete in the second round.
“Leveraging advances in bioengineering, stem cell technology, microfluidics, bioprinting and other fields will generate 3-D systems that help identify new treatments and could enable personalized therapies for patients,” said NEI Director Paul A. Sieving, M.D., Ph.D.
In December 2018, NEI will award up to $100,000 each to as many as six teams whose models best address the scientific criteria outlined in the challenge announcement. The final submissions will be accepted in March 2020, and submitting teams will have the opportunity to win $400,000 plus any remaining prize money.
Companies and non-profit organizations are supporting challenge participants by providing in-kind support such as expert consultation, access to optimization and validation platforms for drug screening, discounts on products and reagents, and other incentives.
Details of the 3-D Retina Organoid Challenge prize competition are available at https://nei.nih.gov/3DROC. For more information about the logistics of the challenge and the criteria for evaluating solutions, visit challenge.gov and search NEI 3-D ROC 2020. A WebEx information session will be held on February 16 at 3:00 p.m.-3:30 p.m. ET for interested participants. The link is: http://bit.ly/2n7wOtb, the meeting number is 627 011 787 and the password is 3DROCS!
NEI leads the federal government’s research on the visual system and eye diseases. NEI supports basic and clinical science programs to develop sight-saving treatments and address special needs of people with vision loss. For more information, visit https://www.nei.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®